Archive ready

B型慢性肝疾患治療薬「ベムリディ錠25mg」の中国国内で確認された偽造品について|厚生労働省

https://www.mhlw.go.jp/stf/houdou/0000170678.html
April 7, 2026 at 03:02 AM JSTThe archive page, viewer, and downloads use this saved version.
April 7, 2026 at 03:02 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

B型慢性肝疾患治療薬「ベムリディ錠25mg」の中国国内で確認された偽造品について|厚生労働省

Open the archived HTML with saved-time metadata attached.

StartedApril 7, 2026 at 03:02 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page announces the discovery of counterfeit B-type chronic hepatitis treatment drug "Bemlidia Tablets 25mg" in China. The counterfeit products have Japanese labels on the packaging and bottle. Currently, no counterfeits have been confirmed in Japan and no health damage has been reported. The Ministry of Health, Labour and Welfare urges citizens to contact local health departments or prefectural governments if they encounter such counterfeits, and advises against distribution, dispensing, or consumption. Details on identifying genuine products are available on the manufacturer's website.

B型慢性肝疾患治療薬「ベムリディ錠25mg」の中国国内で確認された偽造品について|厚生労働省 - Saved screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.